CEDUR - German IBD Registry
Observational · No treatment assigned · 1 site · ImmunoRegister gUG
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Ulcerative Colitis (UC), Indeterminate Colitis and Crohn Disease (CD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Crohn Disease Ulcerative Colitis Indterminate Colitis
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 10000 participants are expected to take part.
- Start date: 2018-05-03.
- Main results expected around 2036-05 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Germany.
Main thing being measured
- Crohn's Disease Activity Index (CDAI) (Up to 10 years of follow-up)
In the researchers’ words
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Ulcerative Colitis (UC); Indeterminate Colitis; Crohn Disease (CD) |
| Lead sponsor | ImmunoRegister gUG |
| Enrollment | 10000 (estimated) |
| Start date | 2018-05-03 |
| Primary completion (est.) | 2036-05 |
| First posted | 2026-01-06 |
| Last updated | 2026-01-06 |
| Official title | Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR" |
| ClinicalTrials.gov ID | NCT07319442 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Crohn Disease Ulcerative Colitis Indterminate Colitis Exclusion Criteria: * Other gastrointestinal disorders than above
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| ImmunoRegister gUG | Hamburg | Germany | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.